Refresh

Shasun Pharmaceuticals Ltd.[Merged] - Research Center

524552 SHASUNPHAR Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11
Income

Operating income

1,078.39 934.72 782.76 735.91 567.13
Expenses

Material consumed

646.68 559.11 498.68 476.87 358.57

Manufacturing expenses

56.33 52.02 53.54 49.50 45.95

Personnel expenses

114.11 95.26 76.74 59.52 51.65

Selling expenses

- - - - -

Adminstrative expenses

148.37 138.89 85.66 98.49 72.05

Expenses capitalised

- - - - -

Cost of sales

965.49 845.27 714.63 684.39 528.22

Operating profit

112.91 89.45 68.13 51.52 38.91

Other recurring income

13.92 12.27 13.66 40.96 16.00

Adjusted PBDIT

126.82 101.72 81.78 92.48 54.91

Financial expenses

45.61 35.62 26.49 30.48 22.34

Depreciation

36.85 38.15 31.66 24.73 24.22

Other write offs

- - - - -

Adjusted PBT

44.37 27.95 23.63 37.27 8.36

Tax charges

4.48 -7.28 -2.64 -15.79 3.48

Adjusted PAT

39.89 35.23 26.28 53.06 4.88

Non recurring items

1.46 - - - -

Other non cash adjustments

- - - - -40.53

Reported net profit

41.35 35.23 26.28 53.06 -35.66

Earnigs before appropriation

193.07 161.87 139.21 132.08 81.21

Equity dividend

- 4.70 7.05 9.98 1.22

Preference dividend

- - - - -

Dividend tax

- 0.96 1.44 1.93 0.24

Retained earnings

193.07 156.20 130.71 120.17 79.76
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com